Jessica Tassan
Stock Analyst at Piper Sandler
(0.92)
# 4,038
Out of 5,090 analysts
237
Total ratings
42.3%
Success rate
-1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Reiterated: Buy | $45 → $54 | $36.65 | +47.34% | 23 | Oct 30, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $370 | $298.23 | +24.07% | 9 | Oct 23, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $463 → $504 | $406.97 | +23.84% | 22 | Oct 14, 2026 | |
| ALHC Alignment Healthcare | Reiterated: Buy | n/a | $7.27 | - | 15 | Oct 5, 2026 | |
| OSCR Oscar Health | Reiterated: Buy | $48 | $30.37 | +58.05% | 11 | Sep 23, 2026 | |
| CVS CVS Health | Reiterated: Buy | $99 → $113 | $90.25 | +25.21% | 12 | Aug 26, 2026 | |
| CTEV Claritev | Rated: Buy | $61 → $73 | $24.00 | +204.17% | 11 | Aug 18, 2026 | |
| DOCS Doximity | Reiterated: Buy | $42 → $47 | $32.76 | +43.47% | 14 | Aug 7, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $36 | $21.48 | +67.60% | 12 | Aug 7, 2026 | |
| HUM Humana | Upgraded: Buy | $254 → $463 | $414.50 | +11.70% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $12 | $12.44 | -3.54% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $2 | $1.69 | +18.34% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $95 | $114.32 | -16.90% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $9 | $8.51 | +5.76% | 22 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.30 | n/a | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $12.73 | n/a | 13 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $10 | $5.00 | n/a | 4 | Jan 17, 2024 |
Omnicell
Oct 30, 2026
Reiterated: Buy
Price Target: $45 → $54
Current: $36.65
Upside: +47.34%
The Cigna Group
Oct 23, 2026
Reiterated: Buy
Price Target: $370
Current: $298.23
Upside: +24.07%
UnitedHealth Group
Oct 14, 2026
Reiterated: Buy
Price Target: $463 → $504
Current: $406.97
Upside: +23.84%
Alignment Healthcare
Oct 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.27
Upside: -
Oscar Health
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $30.37
Upside: +58.05%
CVS Health
Aug 26, 2026
Reiterated: Buy
Price Target: $99 → $113
Current: $90.25
Upside: +25.21%
Claritev
Aug 18, 2026
Rated: Buy
Price Target: $61 → $73
Current: $24.00
Upside: +204.17%
Doximity
Aug 7, 2026
Reiterated: Buy
Price Target: $42 → $47
Current: $32.76
Upside: +43.47%
Privia Health Group
Aug 7, 2026
Reiterated: Buy
Price Target: $36
Current: $21.48
Upside: +67.60%
Humana
Jul 30, 2026
Upgraded: Buy
Price Target: $254 → $463
Current: $414.50
Upside: +11.70%
May 28, 2026
Downgraded: Hold
Price Target: $34 → $12
Current: $12.44
Upside: -3.54%
May 12, 2026
Reiterated: Hold
Price Target: $4 → $2
Current: $1.69
Upside: +18.34%
May 6, 2026
Reiterated: Buy
Price Target: $60 → $95
Current: $114.32
Upside: -16.90%
Feb 26, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $8.51
Upside: +5.76%
Sep 5, 2025
Reiterated: Buy
Price Target: $18
Current: $4.30
Upside: n/a
May 23, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $12.73
Upside: n/a
Jan 17, 2024
Reiterated: Hold
Price Target: $13 → $10
Current: $5.00
Upside: n/a